Zinc deficiency developing in treatment for thalassaemia.
D002648:Child; D003676:Deferoxamine / Q000009:adverse effects; D006801:Humans; D008297:Male; D004369:Pentetic Acid / Q000009:adverse effects*; D013789:Thalassemia / Q000628:therapy*; D065227:Transfusion Reaction; D015032:Zinc / Q000172:deficiency*
D004369:Pentetic Acid; D003676:Deferoxamine; D015032:Zinc